Jul 9, 2024, 06:03
Translational Breast Cancer Research Consortium Trial 022 – Annals of Oncology
Annals of Oncology made the following post on X:
“New article in press: Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022.
Waterfall plots displaying the best RANO-BM CNS responses.”
”
Read the study.
Source: Annals of Oncology/X